Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2016 16:14 ET | Source: Otonomy, Inc.

Otonomy Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update

SAN DIEGO, March 07, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
March 03, 2016 07:30 ET | Source: Otonomy, Inc.

Otonomy Initiates Phase 2 Clinical Trial of OTIPRIO™ in Pediatric Patients With Acute Otitis Media With Tympanostomy Tubes

SAN DIEGO, March 03, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
March 02, 2016 07:30 ET | Source: Otonomy, Inc.

Otonomy Announces Commercial Availability of OTIPRIO™

SAN DIEGO, March 02, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
February 29, 2016 07:30 ET | Source: Otonomy, Inc.

Otonomy to Present at Cowen and Company Health Care Conference

SAN DIEGO, Feb. 29, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
February 26, 2016 07:30 ET | Source: Otonomy, Inc.

Otonomy to Report Fourth Quarter and Full Year 2015 Financial Results and Provide Corporate Update

SAN DIEGO, Feb. 26, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
January 26, 2016 07:05 ET | Source: Otonomy, Inc.

Otonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss

SAN DIEGO, Jan. 26, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
January 12, 2016 09:27 ET | Source: Otonomy, Inc.

Otonomy Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

SAN DIEGO, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
January 08, 2016 07:00 ET | Source: Otonomy, Inc.

Otonomy to Present at J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
January 06, 2016 19:39 ET | Source: Otonomy, Inc.

Otonomy Announces Pricing of Public Offering of Common Stock

SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
January 05, 2016 16:01 ET | Source: Otonomy, Inc.

Otonomy Announces Proposed Public Offering of Common Stock

SAN DIEGO, Jan. 05, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...